Novartis' Ciba Vision Unit Has Good Results; Alcon Purchase Pending

The consumer health unit of Novartis, which includes CIBA Vision, has reported a 7 percent increase in net sales to $1.5 billion in the second quarter of 2010. The division's European sales were up by 5 percent to $600 million, with the strongest growth in France, the U.K. and Germany. ...

To continue reading this article register now.

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €7,29 a week!

Buying a membership today will give you:

  • Unlimited access to - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.